Skip to main content
2023 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
Integrated Informatics Institute
Back
Handout Recording

Educational Sessions

Innovation

Emerging Science Considerations for Pharmacists: Nanomedicines and Biosimilars

Monday, December 4, 2023
4:00 PM – 5:00 PM  
Location: ACC, Room 213b, Level 2
CE Credits 1.00 contact hours
Activity #: 0204-0000-23-245-L01-P
Activity Type: Knowledge-based
Target Audience: Pharmacist

Learning Objectives:

  • Discuss the distinguishing characteristics of nanomedicines and their current role in the management of diseases.
  • Identify evaluation criteria for nanomedicines and nanosimilars to support informed formulary decision-making.
  • Summarize the differences between a reference product, a biosimilar product, and an interchangeable product.
  • Explain the biosimilars approval pathway and major challenges biosimilars face in the U.S. market.